Pulmonary Involvement in Patients with Hematological Malignancies

The number of patients treated for hematological malignancies is increasing steadily. To obtain the highest possible cure rates, aggressive treatments have been introduced, including high-dose chemotherapy, stem cell transplantation, and targeted therapies. As a result, overall and disease-free surv...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Azoulay, Elie (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg, 2011.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03066nam a22005055i 4500
001 978-3-642-15742-4
003 DE-He213
005 20151204143929.0
007 cr nn 008mamaa
008 110414s2011 gw | s |||| 0|eng d
020 |a 9783642157424  |9 978-3-642-15742-4 
024 7 |a 10.1007/978-3-642-15742-4  |2 doi 
040 |d GrThAP 
050 4 |a RC86-88.9 
072 7 |a MMKL  |2 bicssc 
072 7 |a MED015000  |2 bisacsh 
082 0 4 |a 616.028  |2 23 
245 1 0 |a Pulmonary Involvement in Patients with Hematological Malignancies  |h [electronic resource] /  |c edited by Elie Azoulay. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg,  |c 2011. 
300 |a XIX, 827 p. 161 illus., 63 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Preamble and Introduction.-Epidemiology -- Diagnostic Strategy in Hematologic Malignancies Patients -- Lung Infections in Patients with Hematologic Malignancies.-Noninfectious Pulmonary Involvement in Patients with Hematologic Malignancies -- Treatment and Difficult Decisions in Patients with Hematologic Malignancies.-Pearls that You Should be Aware of.-Post Face. 
520 |a The number of patients treated for hematological malignancies is increasing steadily. To obtain the highest possible cure rates, aggressive treatments have been introduced, including high-dose chemotherapy, stem cell transplantation, and targeted therapies. As a result, overall and disease-free survival rates have improved substantially; however, this has been achieved at the price of life-threatening toxic and infectious complications that chiefly target the lung. This book provides clinicians caring for patients with hematological malignancies with detailed, up-to-date information on all relevant aspects of pulmonary involvement. Individual sections are devoted to epidemiology, diagnostic strategy, lung infections, non-infectious pulmonary involvement, and treatment, including decision making in patients with acute respiratory failure. Each of these sections contains a number of chapters, all written by leading international experts. In addition, the reader’s attention is drawn to important "pearls" relating to each condition. 
650 0 |a Medicine. 
650 0 |a Critical care medicine. 
650 0 |a Hematology. 
650 0 |a Infectious diseases. 
650 0 |a Respiratory organs  |x Diseases. 
650 0 |a Oncology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Intensive / Critical Care Medicine. 
650 2 4 |a Hematology. 
650 2 4 |a Oncology. 
650 2 4 |a Infectious Diseases. 
650 2 4 |a Pneumology/Respiratory System. 
700 1 |a Azoulay, Elie.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783642157417 
856 4 0 |u http://dx.doi.org/10.1007/978-3-642-15742-4  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)